Literature DB >> 26768367

The epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cells.

Su-Yan Dong1, Yan-Jie Guo1, Ya Feng1, Xin-Xin Cui1, Sheng-Han Kuo2, Te Liu3, Yun-Cheng Wu4.   

Abstract

Both silent information regulator 1 (SIRT1) and hypoxia inducible factor 1 (HIF-1) have been found to play important roles in the pathophysiology of Parkinson's disease (PD). However, their mechanisms and their relationship still require further study. In the present study, we focused on the change and relationship of SIRT1 and HIF-1α in PD. PD cell models were established by using methyl-4-phenylpyridinium (MPP(+)), which induced inhibition of cell proliferation, cell cycle arrest and apoptosis. We found that the expression of HIF-1α and its target genes VEGFA and LDHA increased and that SIRT1 expression was inhibited in MPP(+) treated cells. With further analysis, we found that the acetylation of H3K14 combined with the HIF-1α promoter was dramatically increased in cells treated with MPP(+), which resulted in the transcriptional activation of HIF-1α. Moreover, the acetylation of H3K14 and the expression of HIF-1α increased when SIRT1 was knocked down, suggesting that SIRT1 was involved in the epigenetic regulation of HIF-1α. At last, phenformin, another mitochondrial complex1 inhibitor, was used to testify that the increased HIF-1a was not due to off target effects of MPP(+). Therefore, our results support a link between PD and SIRT1/HIF-1α signaling, which may serve as a clue for understanding PD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylation; Epigenetics; H3K14; Hypoxia inducible factor-1; Parkinson's disease; Silent information regulator 1

Mesh:

Substances:

Year:  2016        PMID: 26768367      PMCID: PMC4766084          DOI: 10.1016/j.bbrc.2016.01.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  HIF1 and oxygen sensing in the brain.

Authors:  Frank R Sharp; Myriam Bernaudin
Journal:  Nat Rev Neurosci       Date:  2004-06       Impact factor: 34.870

2.  Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons.

Authors:  D Alvira; M Yeste-Velasco; J Folch; E Verdaguer; A M Canudas; M Pallàs; A Camins
Journal:  Neuroscience       Date:  2007-06-20       Impact factor: 3.590

3.  Modulation of SIRT1 expression in different neurodegenerative models and human pathologies.

Authors:  M Pallàs; J G Pizarro; J Gutierrez-Cuesta; N Crespo-Biel; D Alvira; M Tajes; M Yeste-Velasco; J Folch; A M Canudas; F X Sureda; I Ferrer; A Camins
Journal:  Neuroscience       Date:  2008-05-03       Impact factor: 3.590

4.  Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+.

Authors:  Min Zhu; Wen-Wei Li; Chuan-Zhen Lu
Journal:  CNS Neurosci Ther       Date:  2013-12-19       Impact factor: 5.243

5.  Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.

Authors:  Anna Ferretta; Antonio Gaballo; Paola Tanzarella; Claudia Piccoli; Nazzareno Capitanio; Beatrice Nico; Tiziana Annese; Marco Di Paola; Claudia Dell'aquila; Michele De Mari; Ermanno Ferranini; Vincenzo Bonifati; Consiglia Pacelli; Tiziana Cocco
Journal:  Biochim Biophys Acta       Date:  2014-02-25

6.  Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.

Authors:  Jie Bai; Hajime Nakamura; Shugo Ueda; Yong-Won Kwon; Toru Tanaka; Sadayuki Ban; Junji Yodoi
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

Review 7.  Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.

Authors:  Zacharoula Konsoula; Frank A Barile
Journal:  J Pharmacol Toxicol Methods       Date:  2012-08-10       Impact factor: 1.950

8.  The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide.

Authors:  Diego Albani; Letizia Polito; Sara Batelli; Stefania De Mauro; Claudia Fracasso; Giuliana Martelli; Laura Colombo; Claudia Manzoni; Mario Salmona; Silvio Caccia; Alessandro Negro; Gianluigi Forloni
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

9.  Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway.

Authors:  Jieming Ye; Zhenhua Liu; Jipeng Wei; Lingli Lu; Yanjun Huang; Lili Luo; Huifang Xie
Journal:  Neurosci Lett       Date:  2013-08-21       Impact factor: 3.046

Review 10.  Hypoxia-inducible factors and the response to hypoxic stress.

Authors:  Amar J Majmundar; Waihay J Wong; M Celeste Simon
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

View more
  12 in total

Review 1.  Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.

Authors:  Weibo Luo; Yingfei Wang
Journal:  Cell Mol Life Sci       Date:  2017-10-14       Impact factor: 9.261

2.  Missense Variants in HIF1A and LACC1 Contribute to Leprosy Risk in Han Chinese.

Authors:  Dong Wang; Yu Fan; Mahadev Malhi; Rui Bi; Yong Wu; Min Xu; Xiu-Feng Yu; Heng Long; Yu-Ye Li; Deng-Feng Zhang; Yong-Gang Yao
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

Review 3.  The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning.

Authors:  Nathalie Khoury; Kevin B Koronowski; Juan I Young; Miguel A Perez-Pinzon
Journal:  Antioxid Redox Signal       Date:  2017-08-07       Impact factor: 8.401

4.  LncRNA MIAT Inhibits MPP+-Induced Neuronal Damage Through Regulating the miR-132/SIRT1 Axis in PC12 Cells.

Authors:  Xiaoni Xu; Yajun Zhang; Yonggang Kang; Shujuan Liu; Yarong Wang; Yinxia Wang; Lin Wang
Journal:  Neurochem Res       Date:  2021-09-12       Impact factor: 3.996

5.  Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1-BMAL1 Pathway in 6-OHDA-Induced Models of Parkinson's Disease.

Authors:  Yali Wang; Dongjun Lv; Wenwen Liu; Siyue Li; Jing Chen; Yun Shen; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Oxid Med Cell Longev       Date:  2018-04-18       Impact factor: 6.543

6.  Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.

Authors:  Jinjing Zhong; Rui Huang; Zhengzheng Su; Mengni Zhang; Miao Xu; Jing Gong; Ni Chen; Hao Zeng; Xueqin Chen; Qiao Zhou
Journal:  Oncotarget       Date:  2017-05-31

7.  Upregulation of miR-200a and miR-204 in MPP+ -treated differentiated PC12 cells as a model of Parkinson's disease.

Authors:  Maryam Talepoor Ardakani; Mahsa Rostamian Delavar; Masoud Baghi; Mohammad Hossein Nasr-Esfahani; Abbas Kiani-Esfahani; Kamran Ghaedi
Journal:  Mol Genet Genomic Med       Date:  2019-02-03       Impact factor: 2.183

8.  Acute Methylmercury Exposure and the Hypoxia-Inducible Factor-1α Signaling Pathway under Normoxic Conditions in the Rat Brain and Astrocytes in Vitro.

Authors:  Jie Chang; Bobo Yang; Yun Zhou; Changsheng Yin; Tingting Liu; Hai Qian; Guangwei Xing; Suhua Wang; Fang Li; Yubin Zhang; Da Chen; Michael Aschner; Rongzhu Lu
Journal:  Environ Health Perspect       Date:  2019-12-18       Impact factor: 9.031

Review 9.  The Critical Role of SIRT1 in Parkinson's Disease: Mechanism and Therapeutic Considerations.

Authors:  Xuan Li; Ya Feng; Xi-Xi Wang; Daniel Truong; Yun-Cheng Wu
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745

10.  Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.

Authors:  Xuan Li; Xin-Xin Cui; Ya-Jing Chen; Ting-Ting Wu; Huaxi Xu; Huiyong Yin; Yun-Cheng Wu
Journal:  Front Aging Neurosci       Date:  2018-04-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.